Purchase Order 75N95023P00408

This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...

<p>The Department of Health and Human Services National Institutes of Health National Institute on Aging (HHS-NIH-NIA) awarded a $600,000 purchase order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide Epigenome Sequencing Services. The contract has a period of performance starting on June 1, 2023 through May 31, 2024 and utilizes a firm fixed price pricing structure. The place of performance will be Potomac, Maryland. No subcontractors were identified.</p>

<p>The National Institutes of Health National Institute on Aging awarded a $600,000 Purchase Order to Psomagen Inc. of Potomac, Maryland to provide Whole Genome Sequencing Services for 1,000 samples. The contract has a period of performance from September 22, 2022 through September 21, 2023 and utilizes a Firm Fixed Price pricing structure. No subcontractors were identified.</p>

This firm-fixed price purchase order for $600,000 was awarded by the National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, to Psomagen, Inc. for whole genome sequencing services. Under the terms of the contract, Psomagen will sequence 1,000 human samples to 30x coverage using Illumina sequencing technologies and deliver raw sequencing data files within 4-6 weeks. The work will be performed in Potomac, Maryland over a one...

This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...

This is a $64,800 firm-fixed price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Psomagen Inc. for RNA sequencing services to support neurodegenerative disease research. The contract has a period of performance from August 1, 2024 to December 31, 2024. Psomagen will provide total RNA sequencing, including library preparation, sequencing, and data delivery, for 324 human samples. This is a non-competitive award, as Psomagen...

This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for epigenome sequencing services using the Illumina NovaSeq platform. The $83,750 firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health. The award was not set aside for small businesses. Psomagen Inc. is an experienced provider of genomic services to federal agencies, having supported research initiatives at the NIH, USDA, and...

The National Institute on Aging (NIA), a civilian agency within the U.S. government, has awarded a $237,440.00 firm fixed-price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide next-generation sequencing analysis services on post-mortem frontal cortex tissues. The contract has an ultimate completion date of July 31, 2025. This award is not associated with a set-aside program. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a multiomics...

This federal contract, awarded by the National Institute on Aging (a civilian agency of the U.S. government), is for the purchase of whole genome sequencing services from the prime contractor, Psomagen Inc. The contract has a total ceiling value of $7,499,725.00 and is set aside for small businesses. Psomagen Inc. is a subsidiary of Macrogen, Inc. that specializes in providing a range of genomic sequencing, bioinformatics, and related services to federal agencies. Through this contract, Psomagen...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...